
The clinical development of zzso 12 zzso as a single agent for systemic cancer therapy has been hindered by its significant toxicity and disappointing zzso zzso The lack of efficacy was accompanied by, and probably related to, the declining biological effects of zzso in the course of repeated administrations at doses approaching the maximum tolerated dose zzso Nevertheless, zzso remains a very promising zzso agent because recent cancer vaccination studies in animal models and humans have demonstrated its powerful zzso zzso zzso zzso may re-enter the arena of cancer zzso Here, we review the immune modulating characteristics of zzso considered responsible for the zzso effects, as well as the results of animal and human cancer vaccination studies with zzso applied as an zzso In addition, we discuss how studies with systemic zzso in cancer patients, and several other lines of evidence, indicate that zzso may exert optimal zzso effects only at low dose zzso zzso the zzso may not constitute the maximum effective dose of zzso for zzso zzso 

